Neuland Laboratories Limited

NSE:NEULANDLAB.NS

12564.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 4,396.0173,850.0973,928.2834,177.4863,629.9394,070.7262,692.52,937.0552,211.6992,300.9892,364.6982,578.4762,008.8672,320.5682,453.9182,413.9282,054.2381,866.7932,038.4371,862.1771,810.0751,518.0241,714.7951,687.4081,539.5751,475.0771,413.6441,444.2891,450.067
Cost of Revenue 3,024.5522,589.7131,785.9151,915.8051,836.0482,086.5891,394.3451,462.0231,194.8961,499.7071,399.9421,467.1641,168.1781,435.7431,426.5691,478.9941,245.6771,144.151,295.9891,139.8091,197.8991,113.4861,127.5071,141.2371,049.333825.99749.544909.049880.123
Gross Profit 1,371.4651,260.3842,142.3682,261.6811,793.8911,984.1371,298.1551,475.0321,016.803801.282964.7561,111.312840.689884.8251,027.349934.934808.561722.643742.448722.368612.176404.538587.288546.171490.242649.087664.1535.24569.944
Gross Profit Ratio 0.3120.3270.5450.5410.4940.4870.4820.5020.460.3480.4080.4310.4180.3810.4190.3870.3940.3870.3640.3880.3380.2660.3420.3240.3180.440.470.3710.393
Reseach & Development Expenses 0349.917000277.576000277.23000210.658000174.114000166.32100049.88469.63800
General & Administrative Expenses 0000000000000000000000000-60.687235.948155.922161.269
Selling & Marketing Expenses 0000000000000000000000000227.43862.11471.432111.326
SG&A 300.666355.844272.447197.221598.885290.255241.089258.742482.997446.828480.367473.374152.513321.927379.019337.792346.315336.75310.283299.048296.226310.361285.98262.655271.108166.751298.062227.354272.595
Other Expenses 48.0753.5721.00630.47820.38980.6429.3312.3915.118-31.60719.0012.86420.559-1.6351.9536.0596.974-7.76510.2245.6965.177-11.6154.0536.38511.1370000
Operating Expenses 300.666355.8441,081.1511,031.886960.547920.256890.686913.783858.749490.067768.18802.765702.087716.703665.432619.014558.745480.894539.029555.694501.081235.946501.217457.334455.487364.198555.415329.101363.432
Operating Income 1,070.799904.541,082.2231,260.273833.3441,144.523416.8563.64158.054317.207196.576308.517138.602168.122361.917315.92249.816241.749203.419166.674111.095168.59286.07188.83734.755323.167150.121206.693204.355
Operating Income Ratio 0.2440.2350.2750.3020.230.2810.1550.1920.0710.1380.0830.120.0690.0720.1470.1310.1220.1290.10.090.0610.1110.050.0530.0230.2190.1060.1430.141
Total Other Income Expenses Net 227.62117.48-37.413-44.333-1.749-42.887-27.449-31.754-23.463-74.455-14.217-32.736-17.8775.779-42.44-29.064-46.714-69.769-46.701-42.132-35.11-86.887-25.946-34.353-27.699-48.31-52.937-52.796-54.447
Income Before Tax 1,298.42922.021,044.811,215.94831.5951,101.636389.351531.886134.591242.753182.359275.781120.732243.901319.477286.856203.102171.98156.718124.54275.98581.70560.12554.4847.056274.85897.185153.897149.908
Income Before Tax Ratio 0.2950.2390.2660.2910.2290.2710.1450.1810.0610.1050.0770.1070.060.1050.130.1190.0990.0920.0770.0670.0420.0540.0350.0320.0050.1860.0690.1070.103
Income Tax Expense 319.693246.401230.908323.462212.805256.19783.869147.28934.93324.94553.00372.0733.38770.97552.12572.45651.472264.93745.61437.65518.91415.39913.2098.9741.37570.72733.6750.0149.408
Net Income 978.727675.619813.902892.478618.79845.439305.482384.59799.658217.807129.356203.71187.345172.926267.352214.4151.63-92.957111.10486.88757.07166.30646.91645.515.681204.13163.515103.887100.5
Net Income Ratio 0.2230.1750.2070.2140.170.2080.1130.1310.0450.0950.0550.0790.0430.0750.1090.0890.074-0.050.0550.0470.0320.0440.0270.0270.0040.1380.0450.0720.069
EPS 76.2852.6663.4469.5648.2365.923.8129.987.7716.9810.0815.886.8113.4820.8416.7111.82-7.258.666.774.455.173.663.550.4422.987.1511.6911.31
EPS Diluted 76.2852.6663.4469.5648.2365.923.8129.977.7716.9710.0815.886.8113.4820.8416.7111.82-7.248.666.774.455.173.663.550.4422.987.1511.6911.31
EBITDA 1,233.5981,069.1661,233.6611,405.35989.5911,279.222550.163695.359291.165355.381343.325431.207277.449340.321467.954414.675345.414264.732291.825255.189191.812140.568163.657154.392102.499369.901188.687245.259242.92
EBITDA Ratio 0.2810.2780.3140.3360.2730.3140.2040.2370.1320.1540.1450.1670.1380.1470.1910.1720.1680.1420.1430.1370.1060.0930.0950.0910.0670.2510.1330.170.168